(11/15/05) Early Stage Biotechnology funding strategies

Present

The Real Deal:
Funding Strategies for Early Stage Biotechnology Companies
Tuesday, November 15, 2005
at the Desmond Hotel and Conference Center
One Liberty Boulevard, Malvern, PA



7:30AM Registration, breakfast & networking
8:30AM Conference begins
Conference concludes by 11:30 AM

SAVE THE DATE!



MODERATORS

Manya Deehr, Esq. Morgan Lewis
Gerianne Tringali DiPiano, CEO, FemmePharma Global Healthcare

Featuring a Showcase of Temple University Centers, Institutes & Services for
Life Sciences & Biotechnology Companies



PANEL DESCRIPTIONS

Life sciences researchers, biotechnology companies, and investors are encouraged to attend this one half day conference to better understand the funding environment for the biotechnology industry. Leading pharmaceutical and investment executives will present panel discussions and answer audience questions. Temple University’s health sciences and engineering resources will be on exhibit.

1. Venture Capital. What can both sides expect in a venture capital financing deal? What are some strategies to cope with demands for board and management control and equity control? When should you walk away from a round of financing?

2. Strategic Alliances. What are big pharmaceutical companies are looking for in a potential partner? How can early-stage companies stand out?

3. Investment Banks. What are the essential components needed for an IPO? The panel will present sample case studies of successful IPOs, along with failures.


Please visit our website for registration details
and more information.



SPONSORS














The Innovation and Entrepreneurship Institute

iei@temple.edu

1810 North 13th Street

201 Speakman Hall (00-006)

Philadelphia, PA 19122



Voice: (215) 204-3082

Fax: (215) 204-3080



http://www.sbm.temple.edu/iei